Co-occurrence of amyotrophic lateral sclerosis and Charcot-Marie-Tooth disease type 2A in a patient with a novel mutation in the mitofusin-2 gene

被引:18
|
作者
Marchesi, Chiara
Ciano, Claudia
Salsano, Ettore
Nanetti, Lorenzo
Milani, Micaela [2 ]
Gellera, Cinzia [2 ]
Taroni, Franco [2 ]
Fabrizi, Gian Maria [3 ]
Uncini, Antonino [4 ,5 ]
Pareyson, Davide [1 ]
机构
[1] IRCCS Fdn, Dept Clin Neurosci, Unit Clin Cent & Peripheral Degenerat Neuropathie, Besta Neurol Inst C, I-20133 Milan, Italy
[2] IRCCS Fdn, Unit Genet Neurodegenerat & Metab Dis, Besta Neurol Inst C, I-20133 Milan, Italy
[3] Univ Verona, Sect Clin Neurol, Dept Neurol & Visual Sci, I-37100 Verona, Italy
[4] Univ G DAnnunzio Fdn, Inst Aging CeSI, Dept Human Motor Sci, Chieti, Italy
[5] Univ G DAnnunzio Fdn, Inst Aging CeSI, Neurodegenerat Dis Unit, Chieti, Italy
关键词
Charcot-Marie-Tooth neuropathy; Amyotrophic Lateral Sclerosis; CMT2A; Mitofusin-2; Motor neuron disease; MFN2; MUTATIONS; NEUROPATHY;
D O I
10.1016/j.nmd.2010.09.009
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Mitofusin-2 gene (MFN2) mutations cause Charcot-Marie-Tooth type 2A (CMT2A), sometimes complicated by additional features such as optic atrophy, hearing loss, upper motor neuron signs and cerebral white-matter abnormalities. Here we report, for the first time, the occurrence of motor neuron disease, consistent with amyotrophic lateral sclerosis (ALS), in a 62-year-old woman affected by early-onset slowly progressive CMT2A, due to a novel MFN2 mutation. After age 60, rate of disease progression changed and she rapidly developed generalised muscle wasting, weakness, and fasciculations, together with dysarthria and dysphagia. Clinical features, EMG findings, and fast progression were consistent with ALS superimposed on CMT. (C) 2010 Elsevier By. All rights reserved.
引用
收藏
页码:129 / 131
页数:3
相关论文
共 50 条
  • [1] A novel mitofusin 2 gene mutation causing Charcot-Marie-Tooth type 2A disease in a Chinese family
    Ching, Chor Kwan
    Lau, Kwok Kwong
    Yu, Kwok Wai
    Chan, Yan Wo Albert
    Mak, Miu Chloe
    CHINESE MEDICAL JOURNAL, 2010, 123 (11) : 1466 - 1469
  • [2] Mutation screening of mitofusin 2 in Charcot-Marie-Tooth disease type 2
    Donald S. McCorquodale
    Gladys Montenegro
    Ainsley Peguero
    Nicole Carlson
    Fiorella Speziani
    Justin Price
    Sean W. Taylor
    Michel Melanson
    Jeffery M. Vance
    Stephan Züchner
    Journal of Neurology, 2011, 258 : 1234 - 1239
  • [3] Mutation screening of mitofusin 2 in Charcot-Marie-Tooth disease type 2
    McCorquodale, Donald S., III
    Montenegro, Gladys
    Peguero, Ainsley
    Carlson, Nicole
    Speziani, Fiorella
    Price, Justin
    Taylor, Sean W.
    Melanson, Michel
    Vance, Jeffery M.
    Zuechner, Stephan
    JOURNAL OF NEUROLOGY, 2011, 258 (07) : 1234 - 1239
  • [4] Role of mitofusin 2 mutations in the physiopathology of Charcot-Marie-Tooth disease type 2A
    Cartoni, Romain
    Martinou, Jean-Claude
    EXPERIMENTAL NEUROLOGY, 2009, 218 (02) : 268 - 273
  • [5] Mitofusin 2 mutation drives cell proliferation in Charcot-Marie-Tooth 2A fibroblasts
    Zanfardino, Paola
    Longo, Giovanna
    Amati, Alessandro
    Morani, Federica
    Picardi, Ernesto
    Girolamo, Francesco
    Pafundi, Mariella
    Cox, Sharon N.
    Manzari, Caterina
    Tullo, Apollonia
    Doccini, Stefano
    Santorelli, Filippo M.
    Petruzzella, Vittoria
    HUMAN MOLECULAR GENETICS, 2022, : 333 - 350
  • [6] Molecular modelling of mitofusin 2 for a prediction for Charcot-Marie-Tooth 2A clinical severity
    Beresewicz, Malgorzata
    Charzewski, Lukasz
    Krzysko, Krystiana A.
    Kochanski, Andrzej
    Zablocka, Barbara
    SCIENTIFIC REPORTS, 2018, 8
  • [7] Restoring mitofusin balance prevents axonal degeneration in a Charcot-Marie-Tooth type 2A model
    Zhou, Yueqin
    Carmona, Sharon
    Muhammad, A. K. M. G.
    Bell, Shaughn
    Landeros, Jesse
    Vazquez, Michael
    Ho, Ritchie
    Franco, Antonietta
    Lu, Bin
    Dorn, Gerald W., II
    Wang, Shaomei
    Lutz, Cathleen M.
    Baloh, Robert H.
    JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (04) : 1756 - 1771
  • [8] Mitochondrial fusion and function in Charcot-Marie-Tooth type 2A patient fibroblasts with mitofusin 2 mutations
    Amiott, Elizabeth A.
    Lott, Paul
    Soto, Jamie
    Kang, Peter B.
    McCaffery, J. Michael
    DiMauro, Salvatore
    Abel, E. Dale
    Flanigan, Kevin M.
    Lawson, Victoria H.
    Shaw, Janet M.
    EXPERIMENTAL NEUROLOGY, 2008, 211 (01) : 115 - 127
  • [9] Mitochondrial Dysfunction and Pharmacodynamics of Mitofusin Activation in Murine Charcot-Marie-Tooth Disease Type 2A
    Franco, Antonietta
    Dang, Xiawei
    Zhang, Lihong
    Molinoff, Perry B.
    Dorn, Gerald W., II
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2022, 383 (02) : 137 - 148
  • [10] A Sporadic Case of Charcot-Marie-Tooth Disease Type 2 with Left Vocal Fold Palsy due to Mitofusin 2 Mutation
    Kanemaru, Kazuki
    Ogawa, Go
    Mochizuki, Hitoshi
    Nakazato, Masamitsu
    Shiomi, Kazutake
    INTERNAL MEDICINE, 2019, 58 (14) : 2091 - 2093